These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 3493074

  • 21. Murine tumor cell lysis by antibody-dependent macrophage-mediated cytotoxicity using syngeneic monoclonal antibodies.
    Kawase I, Komuta K, Ogura T, Fujiwara H, Hamaoka T, Kishimoto S.
    Cancer Res; 1985 Apr; 45(4):1663-8. PubMed ID: 3978634
    [Abstract] [Full Text] [Related]

  • 22. The generation of tumor-specific in vivo protective immunity in the tumor mass from mice rendered tolerant to tumor antigens.
    Sano S, Izumi Y, Sugihara S, Nakajima H, Fujiwara H, Hamaoka T.
    Cancer Immunol Immunother; 1987 Apr; 25(2):105-10. PubMed ID: 3499223
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Studies on the recovery from tolerance to tumor antigens. I. Bone marrow cells from tolerant hosts are not rendered tolerant, but provide potential to reconstitute tumor-specific effector T cell clones.
    Fujiwara H, Sato S, Kosugi A, Fukuzawa M, Hamaoka T.
    Cancer Immunol Immunother; 1987 Apr; 24(2):113-20. PubMed ID: 3493844
    [Abstract] [Full Text] [Related]

  • 25. The augmentation of tumor-specific immunity by virus help. II. Enhanced induction of cytotoxic T lymphocyte and antibody responses to tumor antigens by vaccinia virus-reactive helper T cells.
    Shimizu Y, Fujiwara H, Ueda S, Wakamiya N, Kato S, Hamaoka T.
    Eur J Immunol; 1984 Sep; 14(9):839-43. PubMed ID: 6236991
    [Abstract] [Full Text] [Related]

  • 26. T-T cell interaction in the induction of delayed-type hypersensitivity (DTH) responses: vaccinia virus-reactive helper T cell activity involved in enhanced in vivo induction of DTH responses and its application to augmentation of tumor-specific DTH responses.
    Takai Y, Kosugi A, Yoshioka T, Tomita S, Fujiwara H, Hamaoka T.
    J Immunol; 1985 Jan; 134(1):108-13. PubMed ID: 3155458
    [Abstract] [Full Text] [Related]

  • 27. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A, Naquet P, Van Agthoven A, Bekkhoucha F, Denizot F, Mishal Z, Schmitt-Verhulst AM, Pierres M.
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [Abstract] [Full Text] [Related]

  • 28. Cellular interactions and the role of interleukin 2 in the expression and induction of immunity against a syngeneic murine sarcoma.
    Chou T, Shu S.
    J Immunol; 1987 Sep 15; 139(6):2103-9. PubMed ID: 2957448
    [Abstract] [Full Text] [Related]

  • 29. Importance of Lyt-2+ T-cells in the resistance of melphalan-cured MOPC-315 tumor bearers to a challenge with MOPC-315 tumor cells.
    Barker E, Mokyr MB.
    Cancer Res; 1988 Sep 01; 48(17):4834-42. PubMed ID: 3261626
    [Abstract] [Full Text] [Related]

  • 30. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH, Daynes RA, Hodes RJ.
    J Immunol; 1986 Feb 15; 136(4):1521-7. PubMed ID: 2418117
    [Abstract] [Full Text] [Related]

  • 31. T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells.
    Bianchi R, Fioretti MC, Romani L, Grohmann U, Cenci E, Puccetti P.
    Int J Cancer; 1990 Oct 15; 46(4):653-7. PubMed ID: 2120136
    [Abstract] [Full Text] [Related]

  • 32. Lyt phenotype of H-2b CTL effectors and precursors specific for the SV40 transplantation rejection antigen.
    Flyer DC, Anderson RW, Tevethia SS.
    J Immunol; 1982 Dec 15; 129(6):2368-71. PubMed ID: 6292288
    [Abstract] [Full Text] [Related]

  • 33. Effector phenotypes and mechanisms of antitumor immune reactivity of tumor-immunized and tumor-bearing mice in two syngeneic tumors.
    Fuyama S, Komatsu H, Arai S.
    Cell Immunol; 1991 Oct 01; 137(1):200-15. PubMed ID: 1679379
    [Abstract] [Full Text] [Related]

  • 34. Enhanced tumor growth and metastatic spread of an MH134 variant lacking a part of the MM antigen: a possible role of antibody-dependent cellular cytotoxicity in control of tumor growth and metastases.
    Hara H, Kawase I, Komuta K, Masuno T, Kishimoto S.
    Int J Cancer; 1989 Jul 15; 44(1):137-42. PubMed ID: 2744883
    [Abstract] [Full Text] [Related]

  • 35. Effective activation of resting mouse T lymphocytes by cross-linking submitogenic concentrations of the T cell antigen receptor with either Lyt-2 or L3T4.
    Eichmann K, Jönsson JI, Falk I, Emmrich F.
    Eur J Immunol; 1987 May 15; 17(5):643-50. PubMed ID: 3108015
    [Abstract] [Full Text] [Related]

  • 36. The role of anti-asialo GM1 antibody-sensitive cells in the implementation of tumor-specific T cell-mediated immunity in vivo.
    Yoshioka T, Sato S, Fujiwara H, Hamaoka T.
    Jpn J Cancer Res; 1986 Aug 15; 77(8):825-32. PubMed ID: 3093429
    [Abstract] [Full Text] [Related]

  • 37. Studies on the recovery from tolerance to tumor antigens. II. Accelerated recovery of tumor-specific effector T cells in tolerant mice by applying T-T cell interaction mechanism.
    Sato S, Fujiwara H, Kosugi A, Hamaoka T.
    Cancer Immunol Immunother; 1987 Aug 15; 24(2):121-6. PubMed ID: 3493845
    [Abstract] [Full Text] [Related]

  • 38. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
    Ward BA, Shu S, Chou T, Perry-Lalley D, Chang AE.
    J Immunol; 1988 Aug 01; 141(3):1047-53. PubMed ID: 3260908
    [Abstract] [Full Text] [Related]

  • 39. Effect of helper T cells on prevention of tolerance induction in effector T cells responsible for syngeneic tumor immunity.
    Fujiwara H, Kinouchi T, Tsuchida T, Aoki H, Hamaoka T.
    Gan; 1982 Oct 01; 73(5):766-72. PubMed ID: 6219908
    [Abstract] [Full Text] [Related]

  • 40. Production of colony-stimulating factor by tumor cells and the factor-mediated induction of suppressor cells.
    Tsuchiya Y, Igarashi M, Suzuki R, Kumagai K.
    J Immunol; 1988 Jul 15; 141(2):699-708. PubMed ID: 2968407
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.